Clinical Trials

Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 301 - 320 of 454 trials
Title Investigatorsort icon Disease(s)
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201] 		Hamlin, Paul
  • Lymphoma
    • Hodgkin's Disease
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
[Protocol 11-050] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
[Protocol 12-061] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Inotuzumab Ozogamicin with Rituximab versus Standard Therapy for Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
[Protocol 12-005] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Celecoxib in Young People with Familial Adenomatous Polyposis
[Protocol 10-176] 		Guillem, Jose
  • Colorectal Cancer
    • Colon Cancer
Hereditary Colorectal Cancer Family Registry
[Protocol 01-110] 		Guillem, Jose
  • Colorectal Cancer
  • Hereditary Cancer & Genetics
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192] 		Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Ipilimumab after Completion of Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian Cancer with Measurable Residual Disease
[Protocol 12-152] 		Grisham, Rachel
  • Ovarian Cancer
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049] 		Gounder, Mrinal
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I Study of Narnatumab (IMC-RON8) in Patients with Refractory Solid Tumors
[Protocol 13-018] 		Gounder, Mrinal
  • Solid Tumors
A Phase I Study of Iso-Fludelone in Patients with Advanced Solid Tumors
[Protocol 10-202] 		Gounder, Mrinal
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117] 		Gounder, Mrinal
  • Breast Cancer
  • Colorectal Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer
[Protocol 10-083] 		Goodman, Karyn
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249] 		Goldfarb, Shari
  • Breast Cancer
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Survivorship
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-077] 		Goldberg, Jenna
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II/III Study of Sirolimus plus Prednisone, Sirolimus/Extracorporeal Photopheresis plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host-Disease
[Protocol 10-201] 		Goldberg, Jenna
  • Blood and Marrow Transplantation
    • Transplantation
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016] 		Giralt, Sergio
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
On Our Blog